Q1 2026 Holdings
Filed 2026-05-15 | 27 holdings | $141.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $27.4M | 84,901 | 19.3% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $26.1M | 495,772 | 18.4% |
| Whitehawk Therapeutics Inc(WHWK) | COM | 00032Q104 | $11.8M | 3,410,402 | 8.3% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $9.2M | 441,831 | 6.5% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $8.2M | 111,996 | 5.8% |
| Sutro Biopharma Inc(STRO) | COM | 869367201 | $6.7M | 269,425 | 4.7% |
| Erasca Inc(ERAS) | COM | 29479A108 | $5.7M | 354,575 | 4.0% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $5.0M | 172,847 | 3.6% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $5.0M | 592,108 | 3.5% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $4.5M | 849,076 | 3.2% |
| Minerva Neurosciences(NERV) | COM NEW | 603380205 | $4.3M | 709,500 | 3.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS ORD A | 61559X104 | $3.6M | 191,760 | 2.5% |
| Argen SE(ARGX) | SPONSORED ADR | 04016X101 | $3.4M | 4,690 | 2.4% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $2.6M | 98,339 | 1.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $2.5M | 26,069 | 1.8% |
| 4D Molecular Therapeutics Inc | COM | 35104E104 | $2.3M | 242,255 | 1.6% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $2.1M | 151,067 | 1.5% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $2.0M | 439,464 | 1.4% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $1.6M | 48,234 | 1.1% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $1.6M | 145,900 | 1.1% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $1.3M | 2,224 | 0.9% |
| Ideaya Biosciences Inc(IDYA)Call | CALL | 45166A102 | $1.2M | 350 | 0.8% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $1.1M | 89,358 | 0.8% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $907.9K | 60,808 | 0.6% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $713.1K | 28,919 | 0.5% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $577.2K | 19,335 | 0.4% |
| Unicycive Therapeutics Inc(UNCY) | COM | 90466Y202 | $381.4K | 57,959 | 0.3% |